Ebstein's anomaly of the tricuspid valve prognosis

Revision as of 13:07, 24 June 2011 by Anjelica Montemayor (talk | contribs) (New page: {{CMG}} and Claudia P. Hochberg, M.D. [mailto:chochber@bidmc.harvard.edu] __NOTOC__ '''Associate Editor-In-Chief:''' {{CZ}} ===Adverse prognostic factors are=== a) NYHA Class III or IV ...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] and Claudia P. Hochberg, M.D. [2]

Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [3]

Adverse prognostic factors are

a) NYHA Class III or IV

b) Moderate to severe cardiomegaly

c) Cyanosis or an O2 sat < 90%

d) Disability during infancy

e)Paradoxical emboli

References

Template:SIB

Template:WH

Template:WS